Drug Trial Radar · NCT00546637
Fesoterodine "add-on" Male Overactive Bladder Study
Last checked: Nov 20, 2026Latest source record: Feb 18, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
947
Actual
Start
Nov 2007
Primary completion
Feb 2009
Study completion Feb 2009
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of fesoterodine on overactive bladder symptom improvement when added to ongoing alpha blocker treatment.
Conditions
- Overactive Bladder Syndrome
Interventions
FesoterodineDrug
Fesoterodine 4mg or 8mg
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numerical Change From Baseline in Micturition-Related Urgency Episodes Per 24 Hours at Week 12Time frame: Baseline, Week 12
Locations
137 sites in 19 countries. Site status is shown where the registry gives one.
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Gilbert, Arizona
Pfizer Investigational Site
Gilbert, Arizona
Pfizer Investigational Site
Litchfield Park, Arizona
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
La Mesa, California
Pfizer Investigational Site
Newport Beach, California
Pfizer Investigational Site
San Bernardino, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Aurora, Colorado
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Jupiter, Florida
Pfizer Investigational Site
Orange City, Florida
Pfizer Investigational Site
West Palm Beach, Florida
Pfizer Investigational Site
Dunwoody, Georgia
Pfizer Investigational Site
Evansville, Indiana
Pfizer Investigational Site
Jeffersonville, Indiana
Pfizer Investigational Site
Newburgh, Indiana
Pfizer Investigational Site
Des Moines, Iowa
Pfizer Investigational Site
Iowa City, Iowa
Pfizer Investigational Site
Baltimore, Maryland
Pfizer Investigational Site
Owings Mills, Maryland
Pfizer Investigational Site
Watertown, Massachusetts
Pfizer Investigational Site
Flint, Michigan
Pfizer Investigational Site
Saint Clair Shores, Michigan
Pfizer Investigational Site
Troy, Michigan
Pfizer Investigational Site
Utica, Michigan
Pfizer Investigational Site
West Bloomfield, Michigan
Pfizer Investigational Site
West Bloomfield, Michigan
Pfizer Investigational Site
Minneapolis, Minnesota
Pfizer Investigational Site
Omaha, Nebraska
Pfizer Investigational Site
Sewell, New Jersey
Pfizer Investigational Site
Albany, New York
Pfizer Investigational Site
Garden City, New York
Pfizer Investigational Site
Kingston, New York
Pfizer Investigational Site
New York, New York
Pfizer Investigational Site
Poughkeepsie, New York
Showing 40 of 137 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.